| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |